CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

por Yuan, Yuan, Egelston, Colt, Colunga Flores, Oscar, Chaurasiya, Shyambabu, Lin, David, Chang, Helen, Chong, Leslie Mi Ok, Seiz, Amanda, Shah, Monil, Meisen, W. Hans, Tang, Aileen, Martinez, Norma, Pickett, Wichanee, Murga, Mireya, Yost, Susan E., Stewart, Daphne, Zhang, Jianying, Ede, Nicholas, Modi, Badri, Kessler, Jonathan, Rand, Jamie, Fong, Yuman
Publicado 2023